Scalp Cooling and Compression Therapy for Chemotherapy Alopecia
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preventing chemotherapy-induced alopecia, such as scalp tourniquets and scalp hypothermia, are either ineffective or uncomfortable for patients and do not adequately protect hair follicles from chemotherapy drugs.
Innovation Solution
A method involving scalp cooling to a temperature of 58° F. to 65° F. combined with periodic compression, which can be administered before, during, and after chemotherapy, using a treatment cap assembly with a cooling and compression unit to reduce blood flow to hair follicles and minimize hair loss.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If scalp hypothermia is used to reduce hair loss, then hair loss reduction is achieved (50-70%), but patient comfort deteriorates and hair follicle protection is insufficient
Solution Approach 1:
The patent changes the temperature parameter from extreme hypothermia (below 24°C) to moderate cooling (58°F to 65°F or 14.4°C to 18.3°C), achieving effective hair loss reduction while significantly improving patient comfort. This parameter optimization resolves the contradiction between effectiveness and comfort.
2Reliability
If scalp cooling to below 24°C is applied, then hair loss reduction is achieved, but hair follicle damage by chemotherapy drugs is not prevented
Solution Approach 1:
The patent applies periodic compression (cyclic inflation and deflation of compression bladder) during chemotherapy administration. This periodic mechanical compression, combined with moderate cooling, reduces blood flow to hair follicles in a rhythmic pattern, preventing chemotherapy drugs from reaching follicles while maintaining follicle viability and achieving hair loss reduction.
3Object-affected harmful factors
If compression is applied continuously to reduce blood flow to scalp, then hair follicle protection is improved, but patient comfort and blood circulation are negatively affected
Solution Approach 1:
The patent uses periodic rather than continuous compression, with cyclic inflation and deflation of the compression bladder. This periodic action reduces blood flow to hair follicles during chemotherapy administration while allowing periodic restoration of blood flow, thereby protecting hair follicles from chemotherapy drugs while maintaining patient comfort and adequate blood circulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces hair loss by minimizing exposure of hair follicles to chemotherapy agents while being more comfortable for patients than existing methods, achieving a 50-70% reduction in hair loss with less cooling required.
Implementation Method 1
cooling a scalp of the individual to a temperature of less than about 65° F.
Implementation Method 2
periodically administering compression to the scalp of the individual during the step of administering the dosage of the chemotherapeutic agent
Data Source
AI summary
A system includes a treatment cap assembly and a cooling and compression unit coupled to the treatment cap assembly. The treatment cap assembly comprises a fluid circulating pad configured to circulate a cooling fluid; and a compression hood configured to administer compression to a scalp of an individual wearing the treatment cap assembly. The cooling and compression unit is configured to provide the cooling fluid to the fluid circulating pad and to periodically provide compressed gas to the compression hood. The system can be used in a method that includes administering to an individual a dosage of a chemotherapeutic agent; cooling a scalp of the individual to a temperature of less than about 65° F.; and periodically administering compression to the scalp of the individual during the step of administering the dosage of the chemotherapeutic agent.